Asce Plus Derma Signal Kit Srlv S
NDC Package 72951-010-01
Package Information
Asce Plus Derma Signal Kit Srlv S is a . Marketed by Exocobio Inc., this product is identified by NDC 72951-010.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72951 - Exocobio Inc.
- 72951-010 - Asce Plus Derma Signal Kit Srlv S
- 72951-010-01 - 1 KIT in 1 CARTON * 20 mg in 1 VIAL * 5 mL in 1 VIAL
- 72951-010 - Asce Plus Derma Signal Kit Srlv S
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72951-010-01 identifies a specific commercial package of 1 kit in 1 carton * 20 mg in 1 vial * 5 ml in 1 vial of Asce Plus Derma Signal Kit Srlv S, labeled by Exocobio Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Exocobio Inc. on March 01, 2019. The current certification is valid through October 01, 2021.
How is this Exocobio Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72951001001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.